Introduction: Current studies on the association between serum calcium levels and carotid atherosclerosis have yielded inconsistent results. This study aimed to elucidate this relationship through a comprehensive meta-analysis. Methods: A systematic search of PubMed, Embase, Cochrane Library, Scopus, Web of Science, China National Knowledge Infrastructure (CNKI), Chinese Biomedical Literature Database (CBM), Weipu (VIP), and Wanfang databases was conducted, supplemented by manual retrieval, from their inception to October 2023. Two independent researchers conducted literature searches, data extraction, and quality assessment. Meta-analysis was performed using Review Manager 5.3 software on studies that met the inclusion criteria. Results: The analysis included 9 cross-sectional studies, encompassing a total sample size of 9,720 participants. The meta-analysis revealed a significant statistical difference in serum calcium levels between the carotid atherosclerosis group and the control group (p = 0.03). The standardized mean difference between the two groups was 0.21 (95% CI: 0.02, 0.41) using the control group as a reference. Conclusions: Our systematic analysis indicates a significant positive correlation between serum calcium levels and carotid atherosclerosis.

Carotid artery stenosis, a prevalent cerebrovascular disease, significantly impacts brain blood supply and, in severe cases, can lead to serious cerebrovascular events such as ischemic stroke [1]. It is often a result of carotid atherosclerosis and plaque formation. Various factors influence carotid atherosclerosis and artery stenosis, including non-modifiable risk factors like age, gender, race, and genetics, as well as modifiable factors such as smoking, alcohol consumption, obesity, hypertension, dyslipidemia, diabetes, physical activity, and emotional stress [2‒4]. Literature reviews reveal ongoing research into the relationship between serum calcium levels and carotid atherosclerosis. The findings to date have been mixed; some studies indicate a positive correlation between serum calcium levels and the severity of carotid stenosis [5], while others refute the notion that increased calcium intake or serum levels exacerbate carotid intima-media thickness or carotid atherosclerosis [6]. Therefore, we conducted a meta-analysis and systematic review to clarify the association between serum calcium and carotid atherosclerosis, aiming to contribute new insights for its prevention.

This study is registered with PROSPERO (registration number: CRD42023482551).

Literature Search

Our search strategy involved a combination of subject terms and free words. We explored PubMed, Embase, Cochrane Library, Scopus, Web of Science, China National Knowledge Infrastructure (CNKI), Chinese Biomedical Literature Database (CBM), Weipu (VIP), and Wanfang databases for studies published from inception to October 2023 on the relationship between calcium and carotid atherosclerosis The English search strategy included (1) various terms related to carotid stenosis, such as “Carotid Stenosis,” “Carotid Artery Narrowing,” “Internal/Common/External Carotid Artery Stenosis,” and “Carotid Artery Plaque”; (2) keywords pertaining to serum calcium, including “calcium supplements,” “calcium supplementation,” “calcium intake,” and “serum calcium.” The search was a combination of (1) and (2). In the Chinese search strategy, the terms were (1) various forms of “stenosis,” “atherosclerosis,” “plaque,” and “sclerosis;” (2) different iterations of “carotid” including “internal,” “external,” and “common carotid artery;” (3) “serum calcium,” “calcium intake,” “dietary calcium,” and “calcium supplementation.” The search combined (1), (2), and (3).

Study Selection and Date Extraction

Studies included met the following criteria: (1) observational in nature; (2) inclusion of data on participants’ serum calcium levels or calcium supplementation; (3) outcomes related to carotid atherosclerosis, such as carotid intima-media thickening, stenosis, and plaque. Two researchers independently reviewed the literature based on these criteria, extracted relevant data, and cross-checked the findings. Any discrepancies were resolved by a third reviewer. The extracted data encompassed the first author’s name, publication year, country, study design, sample size, gender and age of participants, prevalence of carotid atherosclerosis, diagnostic criteria for stenosis, and primary study results.

Quality Evaluation

Two researchers independently assessed the quality of the selected studies, with any ambiguities resolved by a third researcher. The quality evaluation criteria from the Agency for Healthcare Research and Quality (AHRQ) for observational studies were applied [7]. This assessment included 11 items such as definition of information sources, inclusion and exclusion criteria, patient continuity, blinding, quality assurance assessments, confounding factors, missing data, response rates, and patient completeness. Each item was rated as “yes,” “no,” or “unclear,” with “yes” scoring 1 point and the others 0. Item 5 was reverse-scored. The maximum score was 11, with ≥8 indicating high quality, 6–7 medium quality, and ≤5 low quality [8].

Statistical Analysis

Review Manager 5.3 software was utilized for the analysis. The I2 statistic assessed heterogeneity, and a forest plot was generated. A fixed-effect model was applied p > 0.1 and I2 < 50%, indicating good homogeneity. Conversely, p < 0.1 and I2 > 50%, indicating substantial heterogeneity, a random-effects model was used. Publication bias was examined using Egger’s test. Standardized mean difference (SMD), 95% CI, and mean or median of serum calcium levels were analyzed using the control group as a reference. Means not reported were estimated using medians and quartiles.

Literature Search

From an initial tally of 5,555 articles identified through a search of nine databases and manual examination of relevant bibliographies, 9 cross-sectional studies encompassing 9,720 individuals were selected for the final analysis (Fig. 1).

Fig. 1.

Study selection.

Study Characteristics and Quality Evaluation

The analysis included 9 cross-sectional studies published between 2002 and 2023, comprising 7 articles in English and 2 in Chinese. The specific characteristics of these studies are detailed in Table 1. The quality of the included articles was appraised using AHRQ’s recommended standards for cross-sectional studies, categorizing all as medium or high quality. Specifically, 3 articles received a score of 8, 4 articles scored 7, and 2 articles scored 6. The details of this evaluation are presented in Table 2.

Table 1.

Basic characteristics of the included studies (9 cross-sectional studies)

Study, yearCountrySource of sampleSample sizeStudy participantsPrevalence of stenosis, %Calcium assessmentDiagnostic criteria for stenosisMain outcome
male/female, %years of age
Liang [9] (2020) China Patients with T2DM admitted to the Department of Endocrinology of the First Affiliated Hospital of Chongqing Medical University 213 65/35 52 Serum calcium Carotid artery ultrasound Serum calcium levels was positively correlated with carotid IMT in patients with T2DM and is a risk factor for carotid atherosclerosis 
Ishizaka [10] (2002) Japan Health screening test takers at Mitsui Memorial Hospital Health Testing Service Center 5,732 66/34 57±10 23 Serum calcium Carotid artery ultrasound Serum calcium was an independent risk factor for carotid plaque, and it was positively correlated 
Rubin [11] (2007) America The Northern Manhattan Study Cohort 1,194 39/61 68±9 57 Serum calcium Carotid artery ultrasound The serum calcium levels of patients with plaque was higher than that of patients without plaque 
Montalcini [12] (2012) Italy Subjects undergoing health screening for cardiovascular risk factors at Mater Domini University Hospital, Catanzaro 472 41/59 50±12 40 Serum calcium Carotid artery ultrasound Normal serum calcium levels was positively correlated with carotid atherosclerosis in obese/overweight people 
Montalcini [13] (2013) Italy Postmenopausal women recruited from women aged 49–65 years 413 0/100 56±7 52 Serum calcium Carotid artery ultrasound Serum calcium levels within the normal range were positively correlated with carotid atherosclerosis in postmenopausal women 
Ramírez-Morros [14] (2017) Spain T2DM patients aged 40–75 years recruited from a hospital in Catalonia 303 40∼75 59 Serum calcium Carotid artery ultrasound Calcium phosphate products were positively correlated with carotid plaque 
Zhu [15] (2021) China Patients with T2DM were admitted to the Department of Endocrinology and Metabolism of the First Affiliated Hospital of Soochow University for the first time 594 56/44 54 (47–61) 39 Serum calcium Carotid artery ultrasound Serum albumin-corrected calcium levels within the normal range were positively correlated with carotid atherosclerotic plaques 
Kang [16] (2014) Korea Patients visiting the health promotion center of a university-affiliated hospital 361 51/49 52±10 20 Serum calcium MRA Corrected serum calcium concentration was positively correlated with the presence and extent of intracranial atherosclerosis 
Yan [17] (2023) China Menopausal women who underwent carotid ultrasound in the Eighth People’s Hospital of Xinjiang Uygur Autonomous Region 438 0/100 57 Serum calcium Carotid artery ultrasound With the increase of serum calcium levels, the risk of carotid plaque decreased nonlinearly 
Study, yearCountrySource of sampleSample sizeStudy participantsPrevalence of stenosis, %Calcium assessmentDiagnostic criteria for stenosisMain outcome
male/female, %years of age
Liang [9] (2020) China Patients with T2DM admitted to the Department of Endocrinology of the First Affiliated Hospital of Chongqing Medical University 213 65/35 52 Serum calcium Carotid artery ultrasound Serum calcium levels was positively correlated with carotid IMT in patients with T2DM and is a risk factor for carotid atherosclerosis 
Ishizaka [10] (2002) Japan Health screening test takers at Mitsui Memorial Hospital Health Testing Service Center 5,732 66/34 57±10 23 Serum calcium Carotid artery ultrasound Serum calcium was an independent risk factor for carotid plaque, and it was positively correlated 
Rubin [11] (2007) America The Northern Manhattan Study Cohort 1,194 39/61 68±9 57 Serum calcium Carotid artery ultrasound The serum calcium levels of patients with plaque was higher than that of patients without plaque 
Montalcini [12] (2012) Italy Subjects undergoing health screening for cardiovascular risk factors at Mater Domini University Hospital, Catanzaro 472 41/59 50±12 40 Serum calcium Carotid artery ultrasound Normal serum calcium levels was positively correlated with carotid atherosclerosis in obese/overweight people 
Montalcini [13] (2013) Italy Postmenopausal women recruited from women aged 49–65 years 413 0/100 56±7 52 Serum calcium Carotid artery ultrasound Serum calcium levels within the normal range were positively correlated with carotid atherosclerosis in postmenopausal women 
Ramírez-Morros [14] (2017) Spain T2DM patients aged 40–75 years recruited from a hospital in Catalonia 303 40∼75 59 Serum calcium Carotid artery ultrasound Calcium phosphate products were positively correlated with carotid plaque 
Zhu [15] (2021) China Patients with T2DM were admitted to the Department of Endocrinology and Metabolism of the First Affiliated Hospital of Soochow University for the first time 594 56/44 54 (47–61) 39 Serum calcium Carotid artery ultrasound Serum albumin-corrected calcium levels within the normal range were positively correlated with carotid atherosclerotic plaques 
Kang [16] (2014) Korea Patients visiting the health promotion center of a university-affiliated hospital 361 51/49 52±10 20 Serum calcium MRA Corrected serum calcium concentration was positively correlated with the presence and extent of intracranial atherosclerosis 
Yan [17] (2023) China Menopausal women who underwent carotid ultrasound in the Eighth People’s Hospital of Xinjiang Uygur Autonomous Region 438 0/100 57 Serum calcium Carotid artery ultrasound With the increase of serum calcium levels, the risk of carotid plaque decreased nonlinearly 

IMT, intima-media thickness; T2DM, type 2 diabetes mellitus; MRA, magnetic resonance angiography.

Table 2.

Results of the quality evaluation of the included studies

ItemLiang [9] (2020)Ishizaka [10] (2002)Rubin [11] (2007)Montalcini [12] (2012)Montalcini [13] (2013)Ramírez-Morros [14] (2017)Zhu [15] (2021)Kang [16] (2014)Yan [17] (2023)
1) Define the source of information (survey, record review) Yes Yes Yes Yes Yes Yes Yes Yes Yes 
2) List inclusion and exclusion criteria for exposed and unexposed subjects (cases and controls) or refer to previous publications Yes Yes Yes Yes Yes Yes Yes Yes Yes 
3) Indicate time period used for identifying patients Yes Yes No Yes Yes No Yes Yes Yes 
4) Indicate whether or not subjects were consecutive if not population-based No No No No No No No No No 
5) Indicate if evaluators of subjective components of study were masked to other aspects of the status of the participants No No No No No No No No No 
6) Describe any assessments undertaken for quality assurance purposes (e.g., test/retest of primary outcome measurements) Yes Yes Yes Yes Yes Yes Yes Yes Yes 
7) Explain any patient exclusions from analysis No No Yes Yes Yes Yes No Yes No 
8) Describe how confounding was assessed and/or controlled No Yes Yes Yes Yes Yes Yes Yes No 
9) If applicable, explain how missing data were handled in the analysis No No No No No No No No No 
10) Summarize patient response rates and completeness of data collection Yes Yes Yes Yes Yes Yes Yes Yes Yes 
11) Clarify what follow-up, if any, was expected and the percentage of patients for which incomplete data or follow-up was obtained No No No No No No No No No 
Total points 
ItemLiang [9] (2020)Ishizaka [10] (2002)Rubin [11] (2007)Montalcini [12] (2012)Montalcini [13] (2013)Ramírez-Morros [14] (2017)Zhu [15] (2021)Kang [16] (2014)Yan [17] (2023)
1) Define the source of information (survey, record review) Yes Yes Yes Yes Yes Yes Yes Yes Yes 
2) List inclusion and exclusion criteria for exposed and unexposed subjects (cases and controls) or refer to previous publications Yes Yes Yes Yes Yes Yes Yes Yes Yes 
3) Indicate time period used for identifying patients Yes Yes No Yes Yes No Yes Yes Yes 
4) Indicate whether or not subjects were consecutive if not population-based No No No No No No No No No 
5) Indicate if evaluators of subjective components of study were masked to other aspects of the status of the participants No No No No No No No No No 
6) Describe any assessments undertaken for quality assurance purposes (e.g., test/retest of primary outcome measurements) Yes Yes Yes Yes Yes Yes Yes Yes Yes 
7) Explain any patient exclusions from analysis No No Yes Yes Yes Yes No Yes No 
8) Describe how confounding was assessed and/or controlled No Yes Yes Yes Yes Yes Yes Yes No 
9) If applicable, explain how missing data were handled in the analysis No No No No No No No No No 
10) Summarize patient response rates and completeness of data collection Yes Yes Yes Yes Yes Yes Yes Yes Yes 
11) Clarify what follow-up, if any, was expected and the percentage of patients for which incomplete data or follow-up was obtained No No No No No No No No No 
Total points 

Assessment of Serum Calcium Levels in the Included Studies

The serum calcium levels assessment in the included studies was compiled and is summarized in Table 3. Carotid artery stenosis, atherosclerosis, plaque, and carotid intima-media thickness thickening groups were the case group, and the group with normal calcium levels was the control group. These 9 cross-sectional studies used serum calcium levels as a key evaluation metric. In the subgroup analysis, notable differences in serum calcium levels were observed between the control group and the case group. Specifically, mean or median blood calcium levels were higher in the case group than in the control group, except for Yan et al. [17].

Table 3.

Evaluation of serum calcium levels in the included studies

Study, yearTotal serum calcium levels, mmol/LControl group, mmol/LCase group, mmol/Lp value
Liang [9] (2020) 2.25±0.14 2.39±0.18 0.022 
Ishizaka [10] (2002) 2.27±0.07 2.27±0.07 2.28±0.08 <0.001 
Rubin [11] (2007) 2.20±0.09 2.19±0.09 2.21±0.09 <0.002 
Montalcini [12] (2012) 2.35±0.10 2.33±0.10 2.35±0.08 0.029 
Montalcini [13] (2013) 2.37±0.11 2.35±0.11 2.38±0.11 0.001 
Ramírez-Morros [14] (2017) 2.31 [2.25–2.34] 2.32 [2.27–2.37] 0.312 
Zhu [15] (2021) 2.22 [2.17–2.27] 2.26 [2.20–2.34] <0.001 
Kang [16] (2014) 2.24±0.08 2.24±0.09 2.26±0.07 0.034 
Yan [17] (2023) 2.45 [2.33–2.55] 2.31 [2.21–2.39] <0.001 
Study, yearTotal serum calcium levels, mmol/LControl group, mmol/LCase group, mmol/Lp value
Liang [9] (2020) 2.25±0.14 2.39±0.18 0.022 
Ishizaka [10] (2002) 2.27±0.07 2.27±0.07 2.28±0.08 <0.001 
Rubin [11] (2007) 2.20±0.09 2.19±0.09 2.21±0.09 <0.002 
Montalcini [12] (2012) 2.35±0.10 2.33±0.10 2.35±0.08 0.029 
Montalcini [13] (2013) 2.37±0.11 2.35±0.11 2.38±0.11 0.001 
Ramírez-Morros [14] (2017) 2.31 [2.25–2.34] 2.32 [2.27–2.37] 0.312 
Zhu [15] (2021) 2.22 [2.17–2.27] 2.26 [2.20–2.34] <0.001 
Kang [16] (2014) 2.24±0.08 2.24±0.09 2.26±0.07 0.034 
Yan [17] (2023) 2.45 [2.33–2.55] 2.31 [2.21–2.39] <0.001 

Heterogeneity Test and Subgroup Analysis

Significant heterogeneity was observed among the 9 articles included in this study (I2 = 93%, p < 0.001), necessitating the use of a random-effects model. There was a large difference in serum calcium levels between the control group and the case group (p = 0.03), and overall the case group had higher serum calcium levels than the control group (Fig. 2a).

Fig. 2.

a Forest plot of meta-analysis. b Subgroup forest plot for regional. c Subgroup forest plot for publication year.

Fig. 2.

a Forest plot of meta-analysis. b Subgroup forest plot for regional. c Subgroup forest plot for publication year.

Close modal

Subgroup analysis was conducted based on study region (Asia and Occident) and publication year (2002–2012, 2013–2023). The results were as follows: (1) study region subgroup – Asia [9, 10, 15‒17]: I2 = 96%, p = 0.37, SMD = 0.19 (95% CI: −0.23 to 0.61); Occident [11‒14, 16]: I2 = 0%, p < 0.01, SMD = 0.24 (95% CI: 0.16–0.32), with no significant difference between the groups (p = 0.82) (Fig. 2b). (2) Publication year subgroup – 2002–2012 [10‒12]: I2 = 0%, p < 0.01, SMD = 0.16 (95% CI: 0.11–0.21); 2013–2023 [9, 13‒17]: I2 = 95%, p = 0.29, SMD = 0.23 (95% CI: −0.19 to 0.65), with no significant difference between the periods (p = 0.76). (Fig. 2c).

Publication Bias Test

With fewer than 10 articles included, the power to assess funnel plot symmetry was insufficient. Therefore, Egger’s test was conducted using R4.3.2 software, yielding a result of p = 0.744 > 0.05, indicating no potential significant bias.

Sensitivity Analysis

Upon sequentially excluding individual studies, the I2 varied between 83% and 93%, and the Hedges effect size varied from 0.15 to 0.33, aligning closely with the combined Hedges effect size of 0.21. These findings affirm the reliability of the meta-analysis results.

We found higher serum calcium levels in patients with carotid atherosclerosis than in controls, a meta-analysis of 9,720 participants (specifically obese/overweight individuals, postmenopausal women, and type 2 diabetes patients) from nine cross-sectional studies. This suggests a positive correlation between elevated serum calcium levels and carotid atherosclerosis, identifying high serum calcium as a potential risk factor, although one study showed a nonlinear negative correlation between serum calcium levels and the risk of carotid plaque. The association of serum calcium with carotid atherosclerosis is controversial.

The relationship between serum calcium and carotid atherosclerosis remains contentious. Variability in study populations, designs, methods, and evaluation approaches of research indicators contribute to these conflicting results. For instance, Montalcini et al. [13] studied 413 postmenopausal women aged 49–65, using carotid ultrasound and serum calcium measurements. They established a positive correlation between serum calcium levels, carotid atherosclerosis, and general risk factors such as age and systolic blood pressure through logistic regression analysis. Some studies have noted either a negative correlation or no correlation between serum calcium levels and carotid atherosclerosis. For example, a cross-sectional survey [17] observed a nonlinear decrease in carotid plaque risk with increasing serum calcium levels among postmenopausal women. Despite these varying findings, the consensus of our study leans toward a possible positive association between serum calcium levels and carotid atherosclerosis.

Mechanisms of the Effect of Serum Calcium on Carotid Atherosclerosis

The results from a cross-sectional survey [17] reveal a nonlinear decrease in carotid plaque risk corresponding to elevated serum calcium levels, suggesting complexities in the influence of serum calcium on carotid plaque. Atherosclerosis develops through calcium mineral absorption and deposition, with increased calcium ion concentration in arterial wall cells being a contributing factor [18, 19]. Prior research identifies high serum calcium as an independent risk factor for arterial vascular calcification severity [20]. Calcium supplementation significantly raises serum calcium levels, potentially accelerating vascular calcification [21, 22] and favoring plaque formation [11, 23]. Additionally, serum calcium concentration correlates with increased carotid plaque thickness in the general population [11], and arterial calcification score is a predictor of atherosclerosis [24].

Causal Relationship between Serum Calcium and Carotid Atherosclerosis

Our study only found differences in serum calcium levels between the carotid atherosclerosis group and the control group and did not conclude a causal relationship between serum calcium levels and the development of carotid atherosclerosis. Studies have shown that elevated serum calcium can increase or decrease the risk of carotid atherosclerosis [5, 6, 25], but whether the severity of carotid atherosclerosis will increase or decrease the serum calcium level is still unknown. In addition, the dose-response relationship between serum calcium level and the incidence and severity of carotid atherosclerosis has not been investigated. Therefore, further investigation into the mechanisms, causality, and dose-response relationship between serum calcium levels and carotid atherosclerosis is necessary, necessitating more prospective studies with larger, multicenter, and diverse populations.

Our study has certain limitations. First, it solely comprises cross-sectional studies, lacking diversity in research methodologies to robustly support the results. The small number of included studies also diminishes the reliability of the outcomes, rendering the verification of the relationship between serum calcium levels and carotid atherosclerosis less convincing. Second, the majority of the included literature focuses on menopausal women or patients with type 2 diabetes mellitus, thus lacking representation of the broader population. Furthermore, the findings might be confounded by factors such as age, sex, and health status, potentially obscuring the actual relationship between serum calcium levels and carotid atherosclerosis. Third, most of the literature included in our study focused on menopausal women or patients with type 2 diabetes mellitus, which lacked representation of the overall population. In addition, the findings may be confounded by other factors, such as age, sex, health status, and so may not fully reflect the true relationship between serum calcium levels and carotid atherosclerosis.

Despite the limitations, our study holds significant research value and implications. By synthesizing data from multiple studies, we observed that serum calcium levels in individuals with carotid atherosclerosis were higher compared to those without stenosis, and the incidence of carotid atherosclerosis was elevated in populations with higher serum calcium levels. These observations suggest a possible positive correlation between serum calcium levels and carotid atherosclerosis. Such findings provide a novel perspective and direction for future research and also offer a reference for clinical practice and the primary prevention of carotid atherosclerosis.

We thank the institutions and individuals who have supported our work. The views expressed in this publication are those of the author(s) and not necessarily those of their institution.

Ethical approval and consent were not required as this study was based on publicly available data.

All authors have no potential conflicts of interest to disclose.

This study was supported by the Natural Science Foundation of Shandong Province (Grant No. ZR2020MH140), Shandong Province Medical Health Science and Technology Development Plan Project (Grant No. 202012050480), and Shandong First Medical University (Shandong Academy of Medical Sciences) Youth Science Foundation Cultivation Grant Program (Grant No. 202201-029).

Huan Li: conceptualization and writing – original draft; Ruicai Xu: data curation and methodology; Yizhi Liu: formal analysis; Yanli Dong: validation; Dongyue He: investigation; Xiaohui Liu: funding acquisition and writing – review and editing; Qinjian Sun: methodology and writing – review and editing; and Xuena Liu: funding acquisition and writing – review and editing.

Additional Information

Huan Li and Ruicai Xu contributed equally to this work.

All data generated or analyzed during this study are included in this article. Further inquiries can be directed to the corresponding author.

1.
Heck
D
,
Jost
A
.
Carotid stenosis, stroke, and carotid artery revascularization
.
Prog Cardiovasc Dis
.
2021
;
65
:
49
54
.
2.
Banerjee
C
,
Chimowitz
MI
.
Stroke caused by atherosclerosis of the major intracranial arteries
.
Circ Res
.
2017
;
120
(
3
):
502
13
.
3.
Zhang
YS
,
Yun
ZJ
,
Ding
XY
.
Analysis of risk factors in patients with a patient with ischemic cerebrovascular disease
.
Chin J Integr Med Cardio-Cerebrovascular Dis
.
2023
;
21
(
09
):
1711
3
.
4.
Ding
X
,
Li
C
,
Yu
K
,
Gao
A
,
Xiao
L
,
Peng
F
, et al
.
Different risk factors between intracranial and extracranial atherosclerotic stenosis in Asian population: a systematic review and meta-analysis
.
Int J Neurosci
.
2014
;
124
(
11
):
834
40
.
5.
Wu
J
,
Xie
J
,
Zhao
Y
,
Gong
L
,
Liu
X
,
Liu
W
.
Serum calcium is related to the degree of artery stenosis in acute ischemic stroke
.
Cell Physiol Biochem
.
2018
;
46
(
3
):
1189
97
.
6.
Lewis
JR
,
Zhu
K
,
Thompson
PL
,
Prince
RL
.
The effects of 3 years of calcium supplementation on common carotid artery intimal medial thickness and carotid atherosclerosis in older women: an ancillary study of the CAIFOS randomized controlled trial
.
J Bone Miner Res
.
2014
;
29
(
3
):
534
41
.
7.
Rostom
A
,
Dubé
C
,
Cranney
A
,
Saloojee
N
,
Sy
R
,
Garritty
C
, et al
.
Celiac disease
. In:
AHRQ evidence report summaries
.
Rockville (MD)
:
Agency for Healthcare Research and Quality (US)
;
2004
.
8.
Liu
J
,
Lu
N
,
Zhang
F-W
,
Niu
X-D
,
Yuan
R-J
,
Li
W-Y
, et al
.
Influence factors of cancer recurrence fear in breast cancer patients: a meta-analysis
.
J Nursing
.
2021
;
28
(
14
):
1
7
.
9.
Liang
MY
,
Feng
ZP
.
Correlation between blood calcium level and carotid artery intima-media thickness in patients type 2 diabetes mellitus
.
J Mod Med Health
.
2020
;
36
(
17
):
2726
9
.
10.
Ishizaka
N
,
Ishizaka
Y
,
Takahashi
E
,
ToodaHashimoto
EH
,
Nagai
R
,
Yamakado
M
, et al
.
Serum calcium concentration and carotid artery plaque: a population-based study
.
J Cardiol
.
2002
;
39
(
3
):
151
7
.
11.
Rubin
MR
,
Rundek
T
,
McMahon
DJ
,
Lee
H-S
,
Sacco
RL
,
Silverberg
SJ
.
Carotid artery plaque thickness is associated with increased serum calcium levels: the Northern Manhattan study
.
Atherosclerosis
.
2007
;
194
(
2
):
426
32
.
12.
Montalcini
T
,
Gorgone
G
,
Pujia
A
.
Serum calcium level is related to both intima-media thickness and carotid atherosclerosis: a neglect risk factor in obese/overweight subjects
.
J Transl Med
.
2012
;
10
(
1
):
114
.
13.
Montalcini
T
,
Terracciano
R
,
Romeo
S
,
Foti
D
,
Gulletta
E
,
Costanzo
FS
, et al
.
Postmenopausal women with carotid atherosclerosis: potential role of the serum calcium levels
.
Nutr Metab Cardiovasc Dis
.
2013
;
23
(
11
):
1141
6
.
14.
Ramírez-Morros
A
,
Granado-Casas
M
,
Alcubierre
N
,
Martinez-Alonso
M
,
Real
J
,
Castelblanco
E
, et al
.
Calcium phosphate product is associated with subclinical carotid atherosclerosis in type 2 diabetes
.
J Diabetes Res
.
2017
;
2017
:
3498368
.
15.
Zhu
H
,
Wang
H
,
Jia
Y
,
Cheng
L
,
Cheng
X
.
Increased serum calcium levels are associated with carotid atherosclerotic plaque in normocalcaemic individuals with type 2 diabetes
.
Ther Adv Endocrinol Metab
.
2021
;
12
:
2042018821995369
.
16.
Kang
K
.
Serum calcium and phosphate concentrations and intracranial atherosclerosis
.
Atherosclerosis
.
2014
;
232
(
1
):
249
53
.
17.
Yan
P
,
Lei
R
,
Li
L
,
Huang
Z
.
Correlation between serum calcium and phosphorus levels and CIMT and carotid plaque in postmenopausal women
.
Int J Lab Med
.
2023
;
44
(
06
):
666
71+76
.
18.
Kang
JC
.
The correlation study between serum trace elements and carotid intima-media thickness in physical examiness
.
Shijiazhuang
:
Hebei Medical University
;
2015
.
19.
Abedin
M
,
Tintut
Y
,
Demer
LL
.
Vascular calcification: mechanisms and clinical ramifications
.
Arterioscler Thromb Vasc Biol
.
2004
;
24
(
7
):
1161
70
.
20.
Yang
LY
.
Effect of blood calcium concentration on vascular calcification in peritoneal dialysis patients
.
Shijiazhuang
:
Hebei Medical University
;
2018
.
21.
Wang
TK
,
Bolland
MJ
,
van PeltHorne
NCAM
,
Mason
BH
,
Ames
RW
,
Grey
AB
, et al
.
Relationships between vascular calcification, calcium metabolism, bone density, and fractures
.
J Bone Miner Res
.
2010
;
25
(
12
):
2777
85
.
22.
Reid
IR
,
Schooler
BA
,
Hannan
SF
,
Ibbertson
HK
.
The acute biochemical effects of four proprietary calcium preparations
.
Aust N Z J Med
.
1986
;
16
(
2
):
193
7
.
23.
Demer
LL
,
Tintut
Y
.
Mineral exploration: search for the mechanism of vascular calcification and beyond: the 2003 Jeffrey M. Hoeg Award lecture
.
Arterioscler Thromb Vasc Biol
.
2003
;
23
(
10
):
1739
43
.
24.
Yildiz
A
,
Tepe
S
,
Oflaz
H
,
Yazici
H
,
Pusuroglu
H
,
Besler
M
, et al
.
Carotid atherosclerosis is a predictor of coronary calcification in chronic haemodialysis patients
.
Nephrol Dial Transplant
.
2004
;
19
(
4
):
885
91
.
25.
Downing
L
,
Islam
MA
.
Influence of calcium supplements on the occurrence of cardiovascular events
.
Am J Health Syst Pharm
.
2013
;
70
(
13
):
1132
9
.